Effect of olfactory impairment and white matter hyperintensities on cognition in Parkinson's disease

Parkinsonism and Related Disorders

Volumn 24, Issue , 2016, Pages 95-99

  Ham, Jee Hyun ^a   Lee, Jae Jung ^a   Sunwoo, Mun Kyung ^b   Hong, Jin Yong ^c   Sohn, Young H ^a   Lee, Phil Hyu ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Bundang Jesaeng Hospital   (South Korea)

^c Yonsei University Wonju College of Medicine   (South Korea)

Author keywords

Cognition; Olfaction; Parkinson's disease; White matter hyperintensities

Indexed keywords

DOPAMINE TRANSPORTER;

AGED; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; EXECUTIVE FUNCTION; FEMALE; FLUENCY DISORDER; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; OLFACTORY CORTEX; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SEMANTICS; STROOP TEST; VISUAL MEMORY; WHITE MATTER INJURY; ANALYSIS OF VARIANCE; COGNITION DISORDERS; COMPLICATION; DIAGNOSTIC IMAGING; IMAGE PROCESSING; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OLFACTION DISORDERS; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; WHITE MATTER;

AGED; ANALYSIS OF VARIANCE; COGNITION DISORDERS; EXECUTIVE FUNCTION; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OLFACTION DISORDERS; PARKINSON DISEASE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; ROC CURVE; SEVERITY OF ILLNESS INDEX; WHITE MATTER;

EID: 84958891747     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2015.12.017     Document Type: Article

References (31)

1. Doty R.L., Stern M.B., Pfeiffer C., Gollomp S.M., Hurtig H.I. Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 1992, 55:138-142.
2. Lee J.E., Cho K.H., Ham J.H., Song S.K., Sohn Y.H., Lee P.H. Olfactory performance acts as a cognitive reserve in non-demented patients with Parkinson's disease. Park. Relat. Disord. 2014, 20:186-191.
3. Ponsen M.M., Stoffers D., Booij J., van Eck-Smit B.L., Wolters E., Berendse H.W. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann. Neurol. 2004, 56:173-181.
4. Baba T., Kikuchi A., Hirayama K., Nishio Y., Hosokai Y., Kanno S., et al. Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson's disease: a 3 year longitudinal study. Brain 2012, 135(Pt 1):161-169.
5. Bitter T., Bruderle J., Gudziol H., Burmeister H.P., Gaser C., Guntinas-Lichius O. Gray and white matter reduction in hyposmic subjects-A voxel-based morphometry study. Brain Res. 2010, 1347:42-47.
6. Cross D., Anzai Y., Stevenson J., Maravilla K., Peskind E., Minoshima S. Decreased olfactory tract fiber integrity in mild cognitive impairment as revealed by diffusion tensor imaging. Proc. Intl. Soc. Mag. Reson. Med. 2012, 2008.
7. Ibarretxe-Bilbao N., Junque C., Marti M.J., Valldeoriola F., Vendrell P., Bargallo N., et al. Olfactory impairment in Parkinson's disease and white matter abnormalities in central olfactory areas: a voxel-based diffusion tensor imaging study. Mov. Disord. 2010, 25:1888-1894.
8. Sunwoo M.K., Jeon S., Ham J.H., Hong J.Y., Lee J.E., Lee J.M., et al. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease. Eur. J. Neurol. 2014, 21:922-928.
9. Fazekas F., Chawluk J.B., Alavi A., Hurtig H.I., Zimmerman R.A. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR. Am. J. Roentgenol. 1987, 149:351-356.
10. Kim K.W., MacFall J.R., Payne M.E. Classification of white matter lesions on magnetic resonance imaging in elderly persons. Biol. Psychiatry 2008, 64:273-280.
11. de Leeuw F.E., de Groot J.C., Bots M.L., Witteman J.C., Oudkerk M., Hofman A., et al. Carotid atherosclerosis and cerebral white matter lesions in a population based magnetic resonance imaging study. J. Neurol. 2000, 247:291-296.
12. Double K.L., Rowe D.B., Hayes M., Chan D.K., Blackie J., Corbett A., et al. Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test. Arch. Neurol. 2003, 60:545-549.
13. Kang Y., Na D. Seoul Neuropsychological Screening Battery 2003, Human Brain Research & Consulting Co., Incheon.
14. Scheltens P., Barkhof F., Leys D., Pruvo J.P., Nauta J.J., Vermersch P., et al. A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J. Neurol. Sci. 1993, 114:7-12.
15. Mai J.K., Paxinos G. The Human Nervous System 2011, Academic Press.
16. Savic I. Imaging of brain activation by odorants in humans. Curr. Opin. Neurobiol. 2002, 12:455-461.
17. Gottfried J.A., Zald D.H. On the scent of human olfactory orbitofrontal cortex: meta-analysis and comparison to non-human primates. Brain Res. Rev. 2005, 50:287-304.
18. Bohnen N.I., Gedela S., Herath P., Constantine G.M., Moore R.Y. Selective hyposmia in Parkinson disease: association with hippocampal dopamine activity. Neurosci. Lett. 2008, 447:12-16.
19. Bohnen N.I., Muller M.L., Kotagal V., Koeppe R.A., Kilbourn M.A., Albin R.L., et al. Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease. Brain 2010, 133(Pt 6):1747-1754.
20. Shin J., Choi S., Lee J.E., Lee H.S., Sohn Y.H., Lee P.H. Subcortical white matter hyperintensities within the cholinergic pathways of Parkinson's disease patients according to cognitive status. J. Neurol. Neurosurg. Psychiatry 2012, 83:315-321.
21. Kandiah N., Mak E., Ng A., Huang S., Au W.L., Sitoh Y.Y., Tan L.C. Cerebral white matter hyperintensity in Parkinson's disease: a major risk factor for mild cognitive impairment. Park. Relat. Disord. 2013, 19:680-683.
22. Lee E.Y., Eslinger P.J., Du G., Kong L., Lewis M.M., Huang X. Olfactory-related cortical atrophy is associated with olfactory dysfunction in Parkinson's disease. Mov. Disord. 2014, 29:1205-1208.
23. Delano-Wood L., Abeles N., Sacco J.M., Wierenga C.E., Horne N.R., Bozoki A. Regional white matter pathology in mild cognitive impairment: differential influence of lesion type on neuropsychological functioning. Stroke 2008, 39:794-799.
24. Hattori T., Orimo S., Aoki S., Ito K., Abe O., Amano A., et al. Cognitive status correlates with white matter alteration in Parkinson's disease. Hum. Brain Mapp. 2012, 33:727-739.
25. Wen W., Sachdev P.S., Chen X., Anstey K. Gray matter reduction is correlated with white matter hyperintensity volume: a voxel-based morphometric study in a large epidemiological sample. Neuroimage 2006, 29:1031-1039.
26. Ham J.H., Yun H.J., Sunwoo M.K., Hong J.Y., Lee J.M., Sohn Y.H., Lee P.H. Topography of cortical thinning associated with white matter hyperintensities in Parkinson's disease. Park. Relat. Disord. 2015, 21:372-377.
27. Fazekas F., Kleinert R., Offenbacher H., Schmidt R., Kleinert G., Payer F., et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993, 43:1683-1689.
28. Abrahams S., Goldstein L.H., Simmons A., Brammer M.J., Williams S.C., Giampietro V.P., et al. Functional magnetic resonance imaging of verbal fluency and confrontation naming using compressed image acquisition to permit overt responses. Hum. Brain Mapp. 2003, 20:29-40.
29. Pereira J.B., Junque C., Marti M.J., Ramirez-Ruiz B., Bartres-Faz D., Tolosa E. Structural brain correlates of verbal fluency in Parkinson's disease. Neuroreport 2009, 20:741-744.
30. Vataja R., Pohjasvaara T., Mantyla R., Ylikoski R., Leppavuori A., Leskela M., et al. MRI correlates of executive dysfunction in patients with ischaemic stroke. Eur. J. Neurol. 2003, 10:625-631.
31. Watters P.A., Patel M. Competition, inhibition, and semantic judgment errors in Parkinson's disease. Brain Lang. 2002, 80:328-339.